European equities are trading mostly in the red, with major German stocks weighing on the sentiment after a series of major downgrades (e.g. Commerzbank, Siemiens) by key financial institutions. DAX is the biggest loser of the European session (DE40: -1.5%), followed by Spanish IBX 35 (SPA35: -1.1%) and Italian FTSE MIB (ITA40: -1%). French stocks are slightly stable (FRA: -0.25%), although CAC40 gave up yesterday’s late session gains. Broad EU50 is down 0.7%.
Amid Eurostoxx 600 sectors, real estate posts the biggest losses, followed by IT, dragged by the biggest players in the region (SAP: -2%, ASML: -2.6%, Infineon: -2.7%). Financials and utilities are also down on fiscal worries in the UK, while energy and healthcare stocks buck the broad pessimism. The unsease is also visible on the bond market, with many national bonds seeing their yields higher.
Volatility in Eurostoxx 600 sectors. Source: Bloomberg Finance LP
Changes for DAX-listed companies. Source: Bloomberg Finance LP
DE40 (D1)
DAX futures broke decisively below the psychological 24,000 level, pausing just above the 100-day exponential moving average (dark purple). The EMA100 now acts as a critical support that could stem further losses, while a break below would expose the late-July low as the next key test. On the upside, a recovery back above the blue uptrend line would strengthen the case for ongoing consolidation.
Source: xStation5
Company news:
-
Deutsche Bank, Siemens Energy, and Argenx will join the Euro Stoxx 50 on Sept. 22, replacing Nokia, Pernod Ricard, and Stellantis. Rheinmetall and BBVA will also be added, while Mercedes-Benz and BASF will exit, reflecting Stoxx’s periodic index review.
-
Fresenius Medical Care shares fell up to 5.9% (the most in entire Eurostoxx 600) after UBS warned earnings could face pressure from weak US dialysis volumes, slowing chronic kidney disease progression, and structurally higher patient mortality. Consensus downgrades are seen as likely, with the price target cut to €38.
-
SMA Solar slashed its 2025 outlook, now guiding for an EBITDA loss of €30–80m versus earlier profit expectations of €70–80m. Sales are cut to €1.45–1.5bn, down from €1.55bn. Weak home & business demand, €170–220m in write-downs, asset impairments, and restructuring drive the downgrade, with expanded cost-cutting measures aimed at saving over €100m annually.
-
Snowflake and Siemens partnered to integrate factory-floor data with AI analytics, aiming to cut downtime, boost quality, and streamline operations. Siemens’ Industrial Edge captures OT data, while Snowflake’s AI Data Cloud turns it into actionable insights.
Daily summary: A green start to the new trading week 📈
NATGAS gains 12% 🚨📈
GOLD returns to ATH levels 📈
Crypto news: Bitcoin and Ethereum on the rise again 📈
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
